APA Citatie

Schriewer, L., Schütze, K., Petry, K., Hambach, J., Fumey, W., Koenigsdorf, J., . . . Bannas, P. (2020). Nanobody-based CD38-specific heavy chain antibodies induce killing of multiple myeloma and other hematological malignancies. Theranostics.

Chicago Style citaat

Schriewer, Levin, et al. "Nanobody-based CD38-specific Heavy Chain Antibodies Induce Killing of Multiple Myeloma and Other Hematological Malignancies." Theranostics 2020.

MLA citatie

Schriewer, Levin, et al. "Nanobody-based CD38-specific Heavy Chain Antibodies Induce Killing of Multiple Myeloma and Other Hematological Malignancies." Theranostics 2020.